Diagnosis of bladder cancer by analysis of urinary fibronectin

Urology

Volumn 65, Issue 2, 2005, Pages 284-289

  Menéndez, Violeta ^a   Fernández Suárez, Antonio ^b   Galán, Juan Antonio ^b   Pérez, Miguel ^b   García López, Francisco ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FIBRONECTIN;

ARTICLE; BLADDER CARCINOMA; CALCULATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER STAGING; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TRANSURETHRAL RESECTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; URINALYSIS;

EID: 13844270908     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.09.028     Document Type: Article

References (15)

1. S. Akiyama, K. Yamada, M. Hayashi The structure of fibronectin and its role in cellular adhesion J Supramol Struct Cell Biochem 16 1981 345 348
2. M.J. Humphries, M. Obara, K. Olden Role of fibronectin in adhesion, migration, and metastasis Cancer Invest 7 1989 373 393
3. N.E. Stathakis, A. Fountas, E. Tsianos Plasma fibronectin in normal subjects and in various disease states J Clin Pathol 34 1981 504 508
4. H.B. Grossman, M. Liebert, G. Wedemeyer Fibronectin distribution in normal and malignant urothelium J Urol 143 1990 418 420
5. W. Gwinner, I. Jackle-Meyer, H. Stolte Origin of urinary fibronectin Lab Invest 69 1993 250 255
6. R.E. Weiss, B.C. Liu, T. Ahlering Mechanisms of human bladder tumor invasion role of protease cathepsin B J Urol 144 1990 798 804
7. S.M. Redwood, B.C. Liu, R.E. Weiss Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s) Cancer 69 1992 1212 1219
8. M. Katayama, F. Hino, Y. Odate Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin Exp Cell Res 185 1989 229 236
9. M. Katayama, F. Hino, K. Kamihagi Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies Clin Chem 37 1991 466 471
10. M. Katayama, K. Kamihagi, K. Nakagawa Increased fragmentation of urinary fibronectin in cancer patients detected by immunoenzymometric assay using domain-specific monoclonal antibodies Clin Chem Acta 217 1993 115 128
11. P.U. Malmstrom, A. Larsson, S. Johansson Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer Br J Urol 72 1993 307 310
12. M. Sanchez-Carbayo, M. Urrutia, J.M. Gonzalez de Buitrago Evaluation of two new urinary tumor markers bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer Clin Cancer Res 6 2000 3585 3594
13. N. Mutlu, L. Turkeri, K. Emerk Analytical and clinical evaluation of a new urinary tumor marker bladder tumor fibronectin in diagnosis and follow-up of bladder cancer Clin Chem Lab Med 41 2003 1069 1074
14. M. Burchardt, T. Burchardt, A. Shabsigh Current concepts in biomarkers technology for bladder cancers Clin Chem 46 2000 595 605
15. S. Eissa, M. Swellam, M. Sadek Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors J Urol 168 2002 465 469